In this interview, Arnaud Delobel, the R&D and Innovation Director at Quality Assistance, speaks with AZoM about the emerging field of gene therapy with adeno-associated viruses (AAVs) and how Wyatt systems can be used to characterize and quantify AAVs and other biotherapeutics.